[ASEAN] Regulatory Insights on MenQuadfi, Islamic Finance & Vaping Controls

August 17
2 mins

Episode Description

This episode covers significant regulatory updates across ASEAN sectors including MenQuadfi vaccine authorisation, Islamic Finance disclosure standards, controls on etomidate vaporisers, and a notable merger transaction.

Key highlights include Malaysia’s collaborative effort between IOSCO and the Islamic Financial Services Board to develop tailored disclosure frameworks for Islamic capital markets, enhancing investor protection and cross-border alignment.

In Singapore, enforcement under the Tobacco and Vaporisers Control Act 1993 has intensified with over 2,400 individuals caught vaping and nine charged for illegal import or supply of etomidate vaporisers, alongside the upcoming cessation of the QuitVape programme.

Additionally, the MenQuadfi vaccine’s authorised indication has expanded to include children as young as six weeks, supported by a joint regulatory assessment led by the Access Consortium.

Finally, the merger involving Wilmar International Limited and Associated British Foods to jointly acquire Hebei Mauri Food Company Limited in China is under review by the European Commission, ensuring competition oversight.

For more information, visit the Carver Agents website.

Articles mentioned:

  1. M.12533 ABF/ WILMAR / HEBEI MAURI
  2. M.12533 ABF/ WILMAR / HEBEI MAURI
  3. Over 2,400 Caught Vaping, Nine Persons Charged for Alleged Import or Supply of Etomidate from April to June 2026
  4. Chair of the IOSCO Growth and Emerging Markets Committee
  5. Summary report – MenQuadfi®
See all episodes